- Stocks
- Pharma & Healthcare
- BDH Industries
BDH Industries share price
NSE: BDHPharma & HealthcareDrug Manufacturers - Specialty & Generic
BDH Industries at a glance
With a market capitalisation of ₹252 Cr, it ranks 2139th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Its return on equity was 13.8% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹29 Cr (+62.9% year on year) and net profit ₹3 Cr (+15.7%), on a standalone basis. Promoters held 49.70% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹252 CrRank 2139 on NSE
- Price to book
- 2.24×FY25
- EPS (TTM)
- ₹18.78to Q4 FY26
- ROE
- 13.8%FY25
- ROCE
- 17.9%FY25
- Debt to equity
- 0.01FY25
- Net profit margin
- 13.9%FY25
- Book value / share
- ₹117.14FY25
- Dividend payout
- 27.9%FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
BDH Industries quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹29 Cr | ₹29 Cr |
| Revenue YoY | −11.2% | −16.1% | −23.1% | −34.3% | +14.5% | +16.8% | +81.1% | +62.9% |
| Net profit | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Net profit YoY | −3.1% | −4.0% | +1.1% | −15.9% | +16.6% | +8.7% | +24.2% | +15.7% |
| Net margin | 9.7% | 14.8% | 17.3% | 14.0% | 9.8% | 13.8% | 11.9% | 9.9% |
| EPS | ₹2.72 | ₹4.18 | ₹4.88 | ₹4.33 | ₹3.17 | ₹4.55 | ₹6.06 | ₹5.00 |
BDH Industries financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹59 Cr | ₹57 Cr | ₹69 Cr | ₹74 Cr | ₹86 Cr | ₹67 Cr |
| Operating profit | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹11 Cr | ₹13 Cr | ₹12 Cr |
| Net profit | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹10 Cr | ₹9 Cr |
| EPS (₹) | ₹10.32 | ₹11.05 | ₹12.55 | ₹14.25 | ₹17.14 | ₹16.11 |
| Cash from operations | ₹11 Cr | −₹4 Cr | ₹3 Cr | ₹6 Cr | −₹2 Cr | ₹15 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹38 Cr | ₹43 Cr | ₹49 Cr | ₹55 Cr | ₹62 Cr | ₹69 Cr |
BDH Industries shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 49.66% | 49.70% | 49.70% | 49.70% | 49.70% | 49.70% |
| Foreign institutions | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% |
| Domestic institutions | — | — | — | — | 0.00% | 0.00% |
| Non-institutions | 50.06% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% |
BDH Industries vs peers
The listed Pharma & Healthcare companies nearest to BDH Industries by market capitalisation.
Ask anything about BDH Industries
Pivot answers on the live chart with evidence you can check, and tests strategies against BDH's own history. Try: “Why has BDH moved over the last three months?” · “Backtest a 50-day moving-average crossover on BDH over five years” · “Compare BDH with ESPIRE on margins and valuation”
Frequently asked questions about BDH Industries
What is the market cap of BDH Industries?
BDH Industries' market capitalisation is ₹252 Cr (₹252 Cr) at the 22 Oct 2026 close, ranking 2139th among the NSE companies Pivot tracks.
What is the ROE and ROCE of BDH Industries?
Return on equity was 13.8% in FY25 and return on capital employed was 17.9% in FY25 (standalone figures).
Is BDH Industries a debt-free company?
BDH Industries is close to debt-free: its debt-to-equity ratio was 0.01 in FY25.
What were BDH Industries' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), BDH Industries reported revenue of ₹29 Cr, +62.9% year on year, and net profit of ₹3 Cr, +15.7% year on year.
What is the shareholding pattern of BDH Industries?
As of 30 Jun 2026: promoters 49.70%, foreign institutions 0.28%, domestic institutions 0.00%, non-institutions 50.03%.
Who are BDH Industries' competitors?
The listed Pharma & Healthcare companies closest to BDH Industries by market cap are Espire Hospital, Zenotech Labs, Everest Organic, Gennex Labs, Kerala Ayur and Nath Bio-Genes (India).
Is BDH Industries a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out BDH Industries' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BDH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with B · all NSE stocks · this page as text